@Pioupiou
Thanks and to add to your post.
"If for convenience we use 47% amortisation, that means that CCP makes a gross 53% on the PDLs it buys. Obviously, there are other expenses and the time value of money, but at the end, CCP makes a healthy NPAT contribution from PDLs. It targets a similar return for unsecured loans, which is why its loans are cheaper than competitors, and why CCP enjoys the support of a large body of better quality borrowers in the unsecured loans sector."
Below is the profit margin on each line of business, i.e. after all expenses are taken out of the gross 53%. As you'd expect the U.S. needs more scale. Consumer lending net margin is lower than AUS/NZD PDLs.
2018 HY 1 2019 HY 2 2019 HY 1 2020 1 AUS/NZD PDL - Revenue 195.7 97.4 92.1 112.8 2 Profit 77.7 39.2 39.7 46.2 3 Margin 39.70% 40.25% 43.11% 40.96% 4 USD PDL - Revenue 24 17.4 23.4 28 5 Profit 2.7 3.8 4 4.7 6 Margin 11.25% 21.84% 17.09% 16.79% 7 Cons. Lending - Revenue 79.3 44.3 49.5 50.1 8 Profit 23 11.5 17.3 13.7 9 Margin 29.00% 25.96% 34.95% 27.35%
"The collecting problem in FY2009, and probably FY2010, was not due to the GFC, it was because the earlier management team had bought more PDLs that CCP was geared to process" ...."This inclines me to think collections may not suffer much in the current crises due to debtors welching."
Agreed and you'd already mentioned this in an earlier post. Yes, the impact of Covid-19 like 2009/10 is likelu that a $1 delayed in collection is different to a $1 not collected in terms of revenue, FV and LVT covenant impact.
Because of AASB 9 accounting standards, the entire Australian debt-buying sector has to value PDLs at "fair value" (FV).
I stand corrected. FV method complicates valuation. Attached is a Baycorp submission on PDL valuation when AASB 9 was being considered.
- Forums
- ASX - By Stock
- CCP
- Why Is Share Price Tanking?
CCP
credit corp group limited
Add to My Watchlist
0.45%
!
$13.34

Why Is Share Price Tanking?, page-233
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.34 |
Change
0.060(0.45%) |
Mkt cap ! $908.0M |
Open | High | Low | Value | Volume |
$13.58 | $13.58 | $13.14 | $4.973M | 373.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1307 | $13.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.37 | 793 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 13.400 |
1 | 38 | 13.340 |
2 | 5973 | 13.140 |
1 | 1007 | 13.000 |
1 | 1 | 12.940 |
Price($) | Vol. | No. |
---|---|---|
13.200 | 5000 | 1 |
13.280 | 579 | 1 |
13.500 | 5000 | 2 |
13.510 | 700 | 1 |
13.580 | 163 | 1 |
Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
Featured News
CCP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online